A disease a medical Allogeneic hematopoietic stem cell transplantation for the treatment of malign
Mr. Zhang, 32 years old, was diagnosed as chronic NK lymphocytosis after his physical examination last year found problems such as enlarged spleen, enlarged lymph nodes, abnormal blood routine and increased NK lymphocytes. A few months later, the patient developed symptoms such as fever, and tests found positive EB virus DNA. Further examination at the gulou hospital affiliated to the medical college of nanjing university confirmed the diagnosis of invasive NK cell leukemia with hemophagocytic syndrome. Doctors first treated the patient with intense chemotherapy to clear the leukemia cells from the patient's body, then transplanted the hematopoietic stem cells from his sister into the patient. Now the patient's blood routine has returned to normal, EB virus DNA negative.
According to the introduction of professor ouyang jian of hematology department, invasive NK cell leukemia is a rare and very dangerous hematological malignancy recognized internationally at present. It is not sensitive to conventional or intensive chemoradiotherapy, with rapid progression of disease course and extremely high mortality rate. Hematopoietic stem cell transplantation (HSCT) is the only effective treatment for this disease, moreover, once it’d be diagnosed, HSCT must be used as soon as possible to improve the chances of life saving.
The treatment of aggressive NK cell leukemia with hemophilic syndrome with positive EB virus by whole homozygous allogeneic hematopoietic stem cell transplantation has only been reported in foreign countries, but not in China. The successful treatment of this case has fully proved that allogeneic hematopoietic stem cell transplantation has a unique effect in the treatment of invasive NK cell leukemia, a rare and malignant hematological disease. Meanwhile, it also suggests that allogeneic hematopoietic stem cell transplantation can also treat viral diseases, such as EB virus infection and AIDS.
- May 16, 2019Shinya yamanaka, a professor at Kyoto university, has won a European patent for his induced pluripotent stem cell (iPS) culture, the first of its kind for Japan, the Kyoto University said. Local media...view
- April 8, 2018The 7th International Conference on Molecular and Cell Biology was held in Xi'an from April 25 to 17, 2017. Countstar was invited to participate in the conference as the leading supplier of cell count...view
- June 18, 2019When a muscle is injured, it signals a dormant, mature stem cell called a satellite cell to "wake up" and begin repairing it. Scientists at the university of Missouri have found that even if the satel...view